Labcorp Holdings Inc. (LH) Total Return:2.80%(TTM)
Over the latest trailing 12-month period, Labcorp Holdings Inc. (LH)'s total return cagr is +2.80%. The comparable SPY value is +24.27%. Year-to-date total return is +6.65%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in LH
$155,735
(15.6x return)
Invested on Jun 14, 1996
Growth of $10,000 in SPY (S&P 500)
$186,345
(18.6x return)
Invested on Jun 14, 1996
Hypothetical Growth of $10,000
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
Recent Performance Indicators
YTD Total Return
+6.7%
1-Year Total Return
+2.8%
Current Dividend Yield
1.08%
Price CAGR vs. Total Return CAGR
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | +1.7% | +2.8% | +1.1% |
| 3 Years | +11.3% | +12.7% | +1.3% |
| 5 Years | +3.7% | +4.8% | +1.1% |
| 10 Years | +9.0% | +9.6% | +0.6% |
| 15 Years | +8.2% | +8.5% | +0.4% |
| 20 Years | +8.5% | +8.8% | +0.3% |
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter